SULF2 and hepatocellular carcinoma: It has been confirmed that SULF2 expressed by HCC cells can induce HSCs into CAFs through the TGF-β/SMAD3 pathway, which may further inhibit apoptosis and promote EMT of HCC cells via the SDF-1/CXCR4-related signaling pathway (20).